ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Clinical trial NCT06415487 · RECRUITING

Trial details

NCT number: NCT06415487
Sponsor: Acepodia Biotech, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2024-08-22
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.